To investigate the impact of AFP on LCSCs, researchers measured the AFP expression in HCC cells firstly, then demonstrated that AFP not only facilitates the expression of proteins associated with cell reprogramming but also promotes the expression of LCSCs markers, including CD44, CD133, and EpCAM. Here, AFP is linked to hepatocellular carcinoma.